Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 1Recovery 1Endobronchial Metastases 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Flumazenil × Clear all
NCT06563063 2024-08-20

Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam

Yonsei University

Phase NA Completed
60 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05435911 2023-01-13

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

Seoul National University Hospital

Phase NA Completed
66 enrolled

Recovery

NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡